ATE306275T1 - Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten - Google Patents

Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Info

Publication number: ATE306275T1
Authority: AT; Austria
Prior art keywords: lithium; viral infections; contain; pharmaceutical preparations; loop diuretic
Prior art date: 1999-12-30

Application number

AT00981496T

Other languages

English (en)

Inventor

Christopher Edward Hartley

Original Assignee

Henderson Morley Res & Dev Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-30

Filing date

2000-12-13

Publication date

2005-10-15

1999-12-30 Priority claimed from GBGB9930813.2A external-priority patent/GB9930813D0/en

2000-01-12 Priority claimed from GB0000683A external-priority patent/GB0000683D0/en

2000-09-21 Priority claimed from GB0023200A external-priority patent/GB0023200D0/en

2000-12-13 Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd

2005-10-15 Application granted granted Critical

2005-10-15 Publication of ATE306275T1 publication Critical patent/ATE306275T1/de

Links

WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 title abstract 2
208000036142 Viral infection Diseases 0.000 title abstract 2
229910052744 lithium Inorganic materials 0.000 title abstract 2
239000002171 loop diuretic Substances 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title 1
239000011885 synergistic combination Substances 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT00981496T 1999-12-30 2000-12-13 Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten ATE306275T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9930813.2A GB9930813D0 (en)	1999-10-15	1999-12-30	Anti-viral treatment
GB0000683A GB0000683D0 (en)	1999-10-15	2000-01-12	Antiviral treatment
GB0023200A GB0023200D0 (en)	1999-12-30	2000-09-21	Synergistic treatment of DNA viral infections
PCT/GB2000/004790 WO2001049300A2 (en)	1999-12-30	2000-12-13	Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium

Publications (1)

Publication Number	Publication Date
ATE306275T1 true ATE306275T1 (de)	2005-10-15

Family

ID=27255466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00981496T ATE306275T1 (de)	1999-12-30	2000-12-13	Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten

Country Status (9)

Country	Link
US (2)	US20030049331A1 (de)
EP (1)	EP1242096B1 (de)
JP (1)	JP2003519186A (de)
KR (1)	KR20020073156A (de)
CN (1)	CN1213757C (de)
AT (1)	ATE306275T1 (de)
AU (1)	AU1873101A (de)
DE (1)	DE60023180D1 (de)
WO (1)	WO2001049300A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2395016C (en) *	1999-12-30	2009-04-14	Henderson Morley Research And Development Limited	Treatment of dna viral infections
DE60139134D1 (de) *	2000-09-21	2009-08-13	Henderson Morley Res & Dev Ltd	Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung
DE602004029651D1 (de)	2003-02-12	2010-12-02	Univ Georgetown	Verwendung von artemisinin zur behandlung von durch onkogene viren gebildeten tumoren und zur behandlung von viralen infektionen
GB2413282B (en) *	2004-04-23	2009-01-14	Henderson Morley Plc	DNA Viral Infections
GB0616451D0 (en) *	2006-08-18	2006-09-27	Henderson Morley Plc	Dna viral infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU556817B2 (en) *	1982-02-03	1986-11-20	Efamol Limited	Topical application of a lithium salt and dihomo-alpha- linolenic acid
GB8320203D0 (en) *	1983-07-27	1983-09-01	Horrobin D F	Anti-viral compositions
GB9023701D0 (en) *	1990-10-31	1990-12-12	Efamol Holdings	Medical treatment
DE4127469A1 (de) *	1991-08-20	1993-02-25	Peter Prof Dr Med Eckert	Arzneimittel und ihre verwendung
AU681629B2 (en) *	1993-03-12	1997-09-04	Keele University	Therapeutic compositions containing a lithium compound and silica
PT705298E (pt) *	1993-12-01	2002-07-31	Bioartificial Gel Technologies Inc	Hidrogel a base de albumina
DE60139134D1 (de) *	2000-09-21	2009-08-13	Henderson Morley Res & Dev Ltd	Diuretikum oder sulfonylharnstoff zur benutzung in antiviraler behandlung

2000
- 2000-12-13 EP EP00981496A patent/EP1242096B1/de not_active Expired - Lifetime
- 2000-12-13 AU AU18731/01A patent/AU1873101A/en not_active Abandoned
- 2000-12-13 WO PCT/GB2000/004790 patent/WO2001049300A2/en not_active Ceased
- 2000-12-13 KR KR1020027008449A patent/KR20020073156A/ko not_active Withdrawn
- 2000-12-13 AT AT00981496T patent/ATE306275T1/de not_active IP Right Cessation
- 2000-12-13 JP JP2001549668A patent/JP2003519186A/ja active Pending
- 2000-12-13 CN CNB008180628A patent/CN1213757C/zh not_active Expired - Fee Related
- 2000-12-13 US US10/168,946 patent/US20030049331A1/en not_active Abandoned
- 2000-12-13 DE DE60023180T patent/DE60023180D1/de not_active Expired - Lifetime
2005
- 2005-09-30 US US11/240,343 patent/US20060029684A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN1414859A (zh)	2003-04-30
EP1242096A2 (de)	2002-09-25
CN1213757C (zh)	2005-08-10
WO2001049300A2 (en)	2001-07-12
EP1242096B1 (de)	2005-10-12
AU1873101A (en)	2001-07-16
WO2001049300A3 (en)	2002-07-11
DE60023180D1 (de)	2006-02-23
US20060029684A1 (en)	2006-02-09
US20030049331A1 (en)	2003-03-13
KR20020073156A (ko)	2002-09-19
JP2003519186A (ja)	2003-06-17

Similar Documents

Publication	Publication Date	Title
ATE261737T1 (de)	2004-04-15	Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und ein herzglykosid enthalten
DE60043305D1 (de)	2009-12-24	Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE296634T1 (de)	2005-06-15	(s,s)-reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
DE60023128D1 (de)	2006-02-23	Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69830728D1 (de)	2005-08-04	Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
ATE276245T1 (de)	2004-10-15	Indolderivate und deren verwendung zur behandlung von u.a. osteoporosis
EP1001782A4 (de)	2002-01-30	5,6-HETEROARYL-DIPYRIDO (2-3-b:3',2'-f) AZEPINE UND DEREN VERWENDUNG ZUR PROPHYLAXE UND BEHANDLUNG VON HIV-INFEKTIONEN
DE69830751D1 (de)	2005-08-04	Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE3785388D1 (de)	1993-05-19	Antivirale peptide und mittel zur behandlung von herpes.
NO934706L (no)	1994-06-22	Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
PT1001775E (pt)	2002-07-31	Medicamento contendo ioimbina e arginina para tratamento de disfuncao erectil
MX9101958A (es)	1992-07-08	Inhibidores de acat de urea de aminosulfonilo
DE69420229D1 (de)	1999-09-30	Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69939075D1 (de)	2008-08-21	Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
ATE306275T1 (de)	2005-10-15	Pharmazeutische zubereitungen zur behandlung von dns viraler infektionen, welche ein schleifendiureticum und lithium enthalten
DE69916488D1 (de)	2004-05-19	Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE69004451D1 (de)	1993-12-16	Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ATE253578T1 (de)	2003-11-15	Oxazinochinolone zur behandlung von viralen infektionen
ATA113492A (de)	1994-08-15	Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven
DE68907569D1 (de)	1993-08-19	Mittel zur behandlung oder vorbeugung von aids.
MA26650A1 (fr)	2004-12-20	Oxo-thia -azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses.
ATE383161T1 (de)	2008-01-15	Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
BG102404A (en)	1998-12-30	The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
DE60024969D1 (de)	2006-01-26	2-methyl-3-butenyl-1-pyrophosphorsäuresalze und mittel zur behandlung von lymphozyten
ATE255417T1 (de)	2003-12-15	Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen

Legal Events

Date	Code	Title	Description
2006-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties